Omada Health, Inc. Increase (Decrease) in Accrued Liabilities
Omada Health, Inc. (OMDA) reported Increase (Decrease) in Accrued Liabilities of -$4.41 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-07
- Omada Health, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $4.75M, a 30.34% increase year-over-year.
- Omada Health, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$9.16M.
- Omada Health, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $2.77M, a 24.34% decline year-over-year.
- Omada Health, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $12.56M, a 164.85% increase year-over-year.
- Omada Health, Inc. increase (decrease) in accrued liabilities for fiscal 2025 was $10.55M, a 97.49% increase from fiscal 2024.
- Omada Health, Inc. increase (decrease) in accrued liabilities for fiscal 2024 was $5.34M, a 35.95% decline from fiscal 2023.
- Omada Health, Inc. increase (decrease) in accrued liabilities for fiscal 2023 was $8.34M.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$4.41M 10-Q · filed 2026-08-07 | -$1.64M derived: sum of 3 quarters · filed 2026-08-07 | $10.92M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$9.16M 10-Q · filed 2026-05-08 | -$6.39M derived: sum of 2 quarters · filed 2026-05-08 | $6.17M derived: sum of 3 quarters · filed 2026-05-08 | $9.81M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $2.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $15.33M derived: sum of 2 quarters · filed 2026-03-06 | $18.98M derived: sum of 3 quarters · filed 2026-08-07 | $10.55M 10-K · filed 2026-03-06 |
| 2025-09-30 | $12.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $16.21M derived: sum of 2 quarters · filed 2026-08-07 | $7.78M 10-Q · filed 2025-11-07 | $11.44M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $3.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$4.78M 10-Q · filed 2026-08-07 | -$1.12M derived: sum of 3 quarters · filed 2026-08-07 | $3.62M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$8.43M 10-Q · filed 2026-05-08 | -$4.76M derived: sum of 2 quarters · filed 2026-05-08 | -$21.00K derived: sum of 3 quarters · filed 2026-05-08 | |
| 2024-12-31 | $3.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $8.40M derived: sum of 2 quarters · filed 2026-03-06 | $5.34M 10-K · filed 2026-03-06 | |
| 2024-09-30 | $4.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $1.68M 10-Q · filed 2025-11-07 | ||
| 2024-06-30 | -$3.06M 10-Q · filed 2025-08-08 | |||
| 2023-12-31 | $8.34M 10-K · filed 2026-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |